Clinical Trial Update: A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight [Phase 3]

View source ↗

Summary

A Phase 3 study is evaluating Cagrilintide and the CagriSema combination in children and adolescents with overweight or obesity; the trial is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• CagriSema (cagrilintide/semaglutide)
• Cagrilintide (cagrilintide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Overweight, Obesity | Phase 3 | Status: RECRUITING